FI86428C - Foerfarande foer framstaellning av terapeutiskt aktiva 10-substituerad-9-fluor-7-oxo-2,3-dihydro-7h-pyrido -/3,2,1-ij/-1,3,4-bensoxadiazin-6-karboxylsyraderivat. - Google Patents

Foerfarande foer framstaellning av terapeutiskt aktiva 10-substituerad-9-fluor-7-oxo-2,3-dihydro-7h-pyrido -/3,2,1-ij/-1,3,4-bensoxadiazin-6-karboxylsyraderivat. Download PDF

Info

Publication number
FI86428C
FI86428C FI873940A FI873940A FI86428C FI 86428 C FI86428 C FI 86428C FI 873940 A FI873940 A FI 873940A FI 873940 A FI873940 A FI 873940A FI 86428 C FI86428 C FI 86428C
Authority
FI
Finland
Prior art keywords
oxo
compound
methyl
dihydro
pyrido
Prior art date
Application number
FI873940A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI86428B (fi
FI873940A (fi
FI873940A0 (fi
Inventor
Masahiro Aoki
Miyako Kamata
Tatsuo Ohtsuka
Nobuo Shimma
Kazuteru Yokose
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of FI873940A0 publication Critical patent/FI873940A0/fi
Publication of FI873940A publication Critical patent/FI873940A/fi
Priority to FI904279A priority Critical patent/FI88041C/fi
Priority to FI904278A priority patent/FI93357C/fi
Application granted granted Critical
Publication of FI86428B publication Critical patent/FI86428B/fi
Publication of FI86428C publication Critical patent/FI86428C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/06Peri-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/58Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems with hetero atoms directly attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI873940A 1986-09-12 1987-09-11 Foerfarande foer framstaellning av terapeutiskt aktiva 10-substituerad-9-fluor-7-oxo-2,3-dihydro-7h-pyrido -/3,2,1-ij/-1,3,4-bensoxadiazin-6-karboxylsyraderivat. FI86428C (fi)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FI904279A FI88041C (fi) 1986-09-12 1990-08-30 Pyrido/3,2,1-ij/-1,3,4-bensoxadiazin-6-karboxylsyraderivat
FI904278A FI93357C (fi) 1986-09-12 1990-08-30 8-hydroksi-1-amino-4-okso-1,4-dihydro-3-kinoliinijohdannaisia

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP86112619 1986-09-12
EP86112619 1986-09-12

Publications (4)

Publication Number Publication Date
FI873940A0 FI873940A0 (fi) 1987-09-11
FI873940A FI873940A (fi) 1988-03-13
FI86428B FI86428B (fi) 1992-05-15
FI86428C true FI86428C (fi) 1992-08-25

Family

ID=8195410

Family Applications (1)

Application Number Title Priority Date Filing Date
FI873940A FI86428C (fi) 1986-09-12 1987-09-11 Foerfarande foer framstaellning av terapeutiskt aktiva 10-substituerad-9-fluor-7-oxo-2,3-dihydro-7h-pyrido -/3,2,1-ij/-1,3,4-bensoxadiazin-6-karboxylsyraderivat.

Country Status (22)

Country Link
JP (3) JPH0696578B2 (pt)
KR (1) KR960002857B1 (pt)
CN (1) CN1017800B (pt)
AT (1) AT389119B (pt)
AU (1) AU602534B2 (pt)
CA (1) CA1336905C (pt)
CZ (1) CZ281195B6 (pt)
DK (1) DK173330B1 (pt)
DZ (1) DZ1124A1 (pt)
FI (1) FI86428C (pt)
HU (1) HU199481B (pt)
IE (1) IE61624B1 (pt)
IL (1) IL83814A (pt)
MC (1) MC1850A1 (pt)
MX (1) MX8302A (pt)
NO (1) NO169125C (pt)
NZ (1) NZ221681A (pt)
PH (1) PH23930A (pt)
PT (1) PT85686B (pt)
SK (1) SK660487A3 (pt)
ZA (1) ZA876636B (pt)
ZW (1) ZW16387A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZW16387A1 (en) * 1986-09-12 1988-05-25 Hoffmann La Roche Tricyclic compounds
JP4820290B2 (ja) * 2004-05-13 2011-11-24 第一三共株式会社 置換ピロリジン誘導体
US7563805B2 (en) * 2005-05-19 2009-07-21 Daiichi Pharmaceutical Co., Ltd. Tri-, tetra-substituted-3-aminopyrrolidine derivative
MX2008011633A (es) 2006-03-13 2008-12-16 Activx Biosciences Inc Aminoquinolonas como inhibidores de gsk-3.
KR101563018B1 (ko) 2007-09-11 2015-10-23 교린 세이야꾸 가부시키 가이샤 Gsk-3 억제제로서의 시아노아미노퀴놀론 및 테트라졸로아미노퀴놀론
JP5373799B2 (ja) 2007-09-12 2013-12-18 杏林製薬株式会社 Gsk−3阻害剤としてのスピロ環式アミノキノロン
FR2928150A1 (fr) * 2008-02-29 2009-09-04 Vetoquinol Sa Sa Nouveaux derives 7-substitues de 3-carboxy-oxadiazino-quinolones, leur preparation et leur application comme anti-bacteriens
EP2145891A1 (en) * 2008-07-09 2010-01-20 Vetoquinol S.A. 9-substituted-5-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials
AU2010221990B2 (en) 2009-03-11 2015-06-04 Kyorin Pharmaceutical Co., Ltd. 7-cycloalkylaminoquinolones as GSK-3 inhibitors
CN107522718B (zh) * 2017-09-14 2019-11-08 浙江国邦药业有限公司 一种马波沙星的合成方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZW16387A1 (en) * 1986-09-12 1988-05-25 Hoffmann La Roche Tricyclic compounds

Also Published As

Publication number Publication date
NO873816D0 (no) 1987-09-11
NO169125C (no) 1992-05-13
FI86428B (fi) 1992-05-15
AU602534B2 (en) 1990-10-18
FI873940A (fi) 1988-03-13
HU199481B (en) 1990-02-28
HUT47294A (en) 1989-02-28
AT389119B (de) 1989-10-25
PT85686A (en) 1987-10-01
FI873940A0 (fi) 1987-09-11
JPH07138256A (ja) 1995-05-30
JPS63132891A (ja) 1988-06-04
ZA876636B (en) 1988-07-27
PT85686B (pt) 1990-05-31
IE61624B1 (en) 1994-11-16
IE872444L (en) 1988-03-12
CZ281195B6 (cs) 1996-07-17
KR880003954A (ko) 1988-06-01
JPH0819120B2 (ja) 1996-02-28
NO873816L (no) 1988-03-14
CZ660487A3 (en) 1996-04-17
DK477287D0 (da) 1987-09-11
JPH07138262A (ja) 1995-05-30
NZ221681A (en) 1990-12-21
JPH0696578B2 (ja) 1994-11-30
AU7811487A (en) 1988-03-17
ATA263887A (de) 1989-03-15
SK278990B6 (sk) 1998-05-06
PH23930A (en) 1990-01-23
JPH0826030B2 (ja) 1996-03-13
SK660487A3 (en) 1998-05-06
NO169125B (no) 1992-02-03
CN1017800B (zh) 1992-08-12
CN87106838A (zh) 1988-05-11
IL83814A (en) 1991-09-16
CA1336905C (en) 1995-09-05
MC1850A1 (fr) 1988-09-30
DZ1124A1 (fr) 2004-09-13
MX8302A (es) 1993-12-01
DK173330B1 (da) 2000-07-24
KR960002857B1 (ko) 1996-02-27
ZW16387A1 (en) 1988-05-25
DK477287A (da) 1988-03-13

Similar Documents

Publication Publication Date Title
EP0237955B1 (en) Quinolonecarboxylic acid derivatives and their preparation
US5312823A (en) 7-azaisoindolinyl-quinolone-carboxylic acid derivatives
US4801584A (en) Pyrido(3,2,1-IJ)-1,3,4 benzoxadiazine derivatives
IE81144B1 (en) 7-(1-Pyrrolidinyl)-3-quinolone-and -naphthyridone-carboxylic acid derivatives processes for their preparation and substituted mono- and bicyclic pyrrolidine derivatives as intermediate products for their preparation and antibacterial agents and feed additives containing them
US4843070A (en) Substituted thiazetoquinoline-3-carboxylic acids and pharmaceutically acceptable salts thereof
HU179927B (en) Process for preparing naphthyridine derivatives
FI86428C (fi) Foerfarande foer framstaellning av terapeutiskt aktiva 10-substituerad-9-fluor-7-oxo-2,3-dihydro-7h-pyrido -/3,2,1-ij/-1,3,4-bensoxadiazin-6-karboxylsyraderivat.
GB2158825A (en) Naphthyridines
DK165635B (da) 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-1,8-naphthyridin-3-carboxy-derivater, farmaceutisk praeparat omfattende saadanne forbindelser, samt fremgangsmaade til fremstilling af forbindelserne
IE65732B1 (en) Heterocylic-substituted quinoline-carboxylic acids
US4864023A (en) Pyrido(3,2,1-IJ)-1,3,4-benzoxadiazine derivatives
KR940006595B1 (ko) 피리돈카르복실산의 아제티딘 유도체, 그의 제조방법 및 이를 함유하는 의약품조성물
DK161457B (da) Quinolincarboxylsyreforbindelse eller hydrater eller farmaceutisk acceptable salte deraf, fremgangsmaade til deres fremstilling samt antibakterielle farmaceutiske praeparater indeholdende disse
CZ280594A3 (en) Derivatives of 1-(2-fluorocyclopropyl)-quinolonecarboxylic acid and 1-(2-fluorocyclopropyl)-naphthyridonecarboxylic acid, process of their preparation and use in medicaments
FI88041B (fi) Pyrido/3,2,1-ij/-1,3,4-bensoxadiazin-6-karboxylsyraderivat
JPH06192262A (ja) 7−(アミノメチル−オキサ−7−アザ−ビシクロ[3.3.0]オクト−7−イル)キノロンカルボン酸および7−(アミノメチル−オキサ−7−アザ−ビシクロ[3.3.0]オクト−7−イル)ナフチリドンカルボン酸誘導体
JPH08253480A (ja) 1,6−ナフチリドンカルボン酸誘導体
NO171162B (no) Pyrido-benzoksadiazinderivater

Legal Events

Date Code Title Description
FG Patent granted

Owner name: F. HOFFMANN-LA ROCHE AG

MA Patent expired